Insilico Medicine Gains MSCI Global Small Cap Index Inclusion
Cambridge, Massachusetts, August 17, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced...
Lipid Metabolism
Advertisement
PhaseV Survey Highlights Clinical Trial Workflow Delays
Boston, Massachusetts, August 17, 2026 PhaseV, an artificial intelligence and machine learning company focused on clinical development, has announced...
Galmed Reports Aramchol Data in Prostate Cancer Models
Ramat Gan, Israel, August 17, 2026 Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology...
Leal Therapeutics Doses First ALS Patient with LTX-002
WORCESTER, Mass. | June 23, 2026 Leal Therapeutics has announced that the first patient has been dosed in the...
Advertisement
